- POSITIVE
Quarterly Revenue Alpa Laboratories Sep-2026 Quarterly Revenue is Rs 32 Cr which is growth of 9.8% YoY.
- NEGATIVE
Quarterly Net Profit Alpa Laboratories Sep-2026 Quarterly Net Profit is Rs -2 Cr which is growth of -1947.9% YoY.
52.80-3.18(-5.68%)
26,079
NSE+BSE Volume
NSE 16 Nov, 2026 3:31 PM (IST)
Alpa Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Alpa Laboratories quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32.2 | 29.8 | 31.2 | 29.9 | 29.3 | 31.1 | 42.4 | 35 | 31.9 | 26.6 | 27.6 | 30.8 | 35.4 | ||
Operating Exp. | 33.2 | 27.9 | 27.8 | 27.5 | 28.5 | 18.7 | 39.5 | 25.4 | 21.7 | 20.9 | 20.1 | 24.9 | 29.1 | |
Operating Profit | -2.2 | -4 | 3.6 | 2.1 | -2.9 | 0.4 | -0.4 | 0.7 | 3.3 | 0.5 | 3.5 | 2.5 | 3.3 | |
Operating Profit Margin % | -7.16% | -16.53% | 11.50% | 7.20% | -11.19% | 2.22% | -0.92% | 2.84% | 13.12% | 2.53% | 14.90% | 9.01% | 10.23% | |
Depr. | 0.8 | 0.7 | 0.2 | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.7 | 0.5 | |
Interest | 0.1 | 0.1 | 0.2 | 0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0 | 0 | |
Profit Before Tax | -1.9 | 1 | 3 | 1.7 | 0.1 | 11.8 | 2.3 | 8.9 | 9.6 | 5.1 | 6.7 | 5.3 | 5.7 | |
Tax | 1.7 | -0.2 | 4.2 | 2 | 3.1 | 0.8 | ||||||||
Net Profit | -1.9 | 1 | 1.4 | 1.9 | 0.1 | 11.8 | -2 | 8.9 | 7.6 | 5.1 | 3.6 | 4.5 | 5.7 | |
EPS Adj. latest | -0.9 | 0.5 | 0.6 | 0.9 | 0.1 | 5.6 | -0.9 | 4.2 | 3.6 | 2.4 | 1.7 | 2.2 | 2.7 | |
Net profit TTM | 2.4 | 4.4 | 15.1 | 11.8 | 18.8 | 26.4 | 19.7 | 25.2 | 20.8 | 18.9 | 16.8 | 17.9 | 18.5 | |
Basic EPS TTM | 1.1 | 2.1 | 7.2 | 5.6 | 9 | 12.5 | 9.4 | 12 | 9.9 | 9 | 8 | 8.5 | 8.8 | |
Results PDF | ||||||||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Alpa Laboratories competitor comparison and performance snapshot within industry
Alpa Laboratories annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Annual Revenue Alpa Laboratories Mar-2026 Annual Revenue is Rs 122 Cr which is growth of -10.5% YoY.
- NEGATIVE
Annual Net Profit Alpa Laboratories Mar-2026 Annual Net Profit is Rs 15 Cr which is growth of -24.0% YoY.
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
-10.5%
2Y CAGR
-0.9%
3Y CAGR
5.9%
5Y CAGR
3.6%
7Y CAGR
5.6%
10Y CAGR
7.4%
Total Revenue Annual is falling faster than historical averages.
Net Profit Ann.
1Y CHG
-23.9%
2Y CAGR
-5.5%
3Y CAGR
6%
5Y CAGR
15.5%
7Y CAGR
27.8%
10Y CAGR
6.9%
Net Profit Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
-4.7%
2Y CAGR
0.9%
3Y CAGR
6.5%
5Y CAGR
2.7%
7Y CAGR
4.2%
10Y CAGR
8.2%
Operating Expenses Annual Cr is falling faster than historical averages.
Alpa Laboratories balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Alpa Laboratories Mar-2026 Total Shareholders Fund is Rs 197 Cr which is growth of 8.1% YoY.
- POSITIVE
Total Assets Alpa Laboratories Mar-2026 Total Assets is Rs 251 Cr which is growth of 7.9% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10.8% | 10.8% | 196.6 | 181.8 | 162 | 144.5 | 131.6 | 117.5 | 110.2 | 105.9 | 103.2 | 98.5 | 94.3 | ||
Minority Interest Liability Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
2.1% | 75.2% | 3.3 | 4.5 | 2.4 | 3.1 | 4.7 | 0.2 | 0.2 | 0.4 | 0.6 | 0.5 | 0.6 | ||
19.9% | 9.6% | 51.5 | 46.7 | 28.1 | 29.9 | 28.8 | 32.5 | 20.8 | 22.3 | 22.7 | 30.1 | 50.1 | ||
Total Capital Plus Liabilities Ann. | 12.3% | 10.9% | 251.4 | 233 | 192.4 | 177.5 | 165.1 | 150.2 | 131.2 | 128.6 | 126.6 | 129.1 | 145.1 | |
42.4% | 18.1% | 20.2 | 20.7 | 11.5 | 7 | 9.3 | 8.8 | 7.2 | 5.9 | 6.1 | 5.2 | 4.5 | ||
13.3% | 7% | 42.6 | 41.5 | 32.7 | 29.3 | 27.4 | 30.4 | 36.9 | 35.7 | 30.6 | 21.4 | 29.2 | ||
12.1% | 11.7% | 208.8 | 191.5 | 159.8 | 148.2 | 137.7 | 119.9 | 94.3 | 92.9 | 96.1 | 107.7 | 115.8 | ||
Total Assets Ann. | 12.3% | 10.9% | 251.4 | 233 | 192.4 | 177.5 | 165.1 | 150.2 | 131.2 | 128.6 | 126.6 | 129.1 | 145.1 | |
Contingent Liabilities plus Commitments Ann. | 60.7% | 20.9% | 13.7 | 6.7 | 10.6 | 3.3 | 5.3 | 5.3 | 5.8 | 4.1 | 3.1 | 2.2 | 41.8 | |
Bonus Equity Share Capital Ann. | - | - | ||||||||||||
Non Current Investments Unquoted Book Value Ann. | 1% | -8.3% | 6.6 | 7.4 | 6.9 | 6.4 | 5.9 | 10.2 | 17.3 | 29.3 | 23.7 | 15.6 | 15 | |
Current Investments Unquoted Book Value Ann. | 777.2% | 239.3% | 135 | 110.5 | 91.1 | 0.2 | 0.2 | 0.3 | 39.3 | 30 | 17.7 | 7.9 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
7.9%
2Y CAGR
14.3%
3Y CAGR
12.3%
5Y CAGR
10.9%
7Y CAGR
10%
10Y CAGR
5.7%
Total Assets Annual growth is lower than historical averages.
Total Current Liabilities Ann.
1Y CHG
10.3%
2Y CAGR
35.4%
3Y CAGR
19.9%
5Y CAGR
9.6%
7Y CAGR
12.7%
10Y CAGR
0.3%
Total Current Liabilities Annual Cr growth is stable compared to historical averages.
Total ShareHolders Funds Ann.
1Y CHG
8.1%
2Y CAGR
10.2%
3Y CAGR
10.8%
5Y CAGR
10.8%
7Y CAGR
9.2%
10Y CAGR
7.6%
Total ShareHolders Funds Annual growth is lower than historical averages.
Alpa Laboratories ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Alpa Laboratories Mar-2026 Book Value Per Share is 93 Rs which is growth of 8.1% YoY.
- POSITIVE
ROE Alpa Laboratories Mar-2026 ROE is 8% which is growth of 3.2% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BVSH Ann. | 10.8% | 10.8% | 93.4 | 86.4 | 77 | 68.7 | 62.6 | 55.9 | 52.4 | 50.3 | 49.1 | 46.8 | 44.8 | |
RoA Ann. % | -5.8% | 4.2% | 5.94% | 8.44% | 8.71% | 7.11% | 8.55% | 4.83% | 3.10% | 2.12% | 3.76% | 4.64% | 5.33% | |
ROE Ann. % | -4.5% | 4.2% | 7.60% | 10.82% | 10.35% | 8.73% | 10.73% | 6.18% | 3.69% | 2.57% | 4.61% | 6.08% | 8.20% | |
ROCE Ann. % | -8.2% | -1.7% | 8.46% | 14.01% | 12.81% | 10.94% | 14.54% | 9.24% | 4.77% | 4.67% | 7.33% | 13.07% | 12.72% | |
Total Debt to Total Equity Ann. | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0.3 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
-29.8%
2Y CAGR
-14.3%
3Y CAGR
-4.5%
5Y CAGR
4.2%
7Y CAGR
16.8%
10Y CAGR
-0.8%
ROE Annual % is falling faster than historical averages.
RoA Ann. %
1Y CHG
-29.6%
2Y CAGR
-17.4%
3Y CAGR
-5.8%
5Y CAGR
4.2%
7Y CAGR
15.9%
10Y CAGR
1.1%
RoA Annual % is falling faster than historical averages.
Current Ratio Ann.
2Y CAGR
-15.2%
3Y CAGR
-6.4%
5Y CAGR
2.1%
7Y CAGR
-0.3%
10Y CAGR
6%
Current Ratio Annual is falling faster than historical averages.
Alpa Laboratories cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Cash From Operating Activity Alpa Laboratories Mar-2026 Cash From Operating Activity is Rs 10 Cr which is growth of -45.9% YoY.
- NEGATIVE
Net Cash Flow Alpa Laboratories Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of -210.8% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4.4% | - | 10 | 18.4 | 3.7 | 8.8 | 2.2 | -1.5 | 17.7 | -0.8 | -7.3 | -8.1 | -24.8 | ||
Cash from Investing Act. Ann. | - | - | -11.6 | -12.5 | -12.5 | 2.1 | -17.2 | 5.8 | -11.3 | -2.4 | -15.8 | 1.1 | -7 | |
Cash from Financing Act. Ann. | - | - | 1.2 | -5.5 | 2.3 | -3.5 | 5.4 | -0 | -1.4 | -4.9 | 4.4 | -2.4 | -5.6 | |
- | - | -0.5 | 0.4 | -6.5 | 7.5 | -9.6 | 4.3 | 5 | -8.1 | -18.7 | -9.4 | -37.4 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
-45.7%
2Y CAGR
64.4%
3Y CAGR
4.4%
Cash from Operating Activity Annual is falling faster than historical averages.
Cash from Financing Act. Ann.
2Y CAGR
-27.8%
Cash from Financing Annual Activity growth is lower than historical averages.
